$17.44
0.352.05%
At Close: -
$17.44
00.00%
After Hours: 4:45 PM EDT
15 minutes delayed
Cullinan Therapeutics: Insider buying and selling updated today.
May 08, 2024 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -8K | $16.27 | -$1.56M | SELL | -5.81% | 129.582K | May 06 - May 07 | View |
Feb 02, 2024 | Corrine Savill | CHIEF BUSINESS OFFICER | 0 | $10.24 | -$475.20K | SELL-OPTIONS | 0.00% | 165.99K | Feb 01 | View |
Jan 30, 2024 | Corrine Savill | CHIEF BUSINESS OFFICER | 0 | $9.20 | -$391.60K | SELL-OPTIONS | 0.00% | 165.99K | Jan 29 | View |
Jan 24, 2024 | Corrine Savill | CHIEF BUSINESS OFFICER | -4.125K | $8.31 | -$338.25K | SELL | -2.42% | 165.99K | Jan 22 - Jan 23 | View |
Dec 27, 2023 | NADIM AHMED | PRESIDENT AND CEO | -4.272K | $9.24 | -$39.47K | SELL | -3.69% | 111.55K | Dec 26 | View |
Dec 22, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -1.86K | $8.50 | -$15.81K | SELL | -3.20% | 56.191K | Dec 21 | View |
Dec 22, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -1.4K | $8.50 | -$11.90K | SELL | -3.07% | 44.133K | Dec 21 | View |
Dec 22, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -1.92K | $8.50 | -$16.32K | SELL | -2.24% | 83.919K | Dec 21 | View |
Dec 22, 2023 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -1.145K | $8.50 | -$9.73K | SELL | -1.29% | 87.582K | Dec 21 | View |
Dec 20, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -386 | $8.22 | -$3.17K | SELL | -0.66% | 58.051K | Dec 18 | View |
Dec 20, 2023 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -238 | $8.22 | -$1.96K | SELL | -0.27% | 88.727K | Dec 18 | View |
Dec 20, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -290 | $8.22 | -$2.38K | SELL | -0.63% | 45.533K | Dec 18 | View |
Dec 20, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -398 | $8.22 | -$3.27K | SELL | -0.46% | 85.839K | Dec 18 | View |
Dec 13, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -1.926K | $7.81 | -$15.04K | SELL | -2.18% | 86.237K | Dec 12 | View |
Dec 13, 2023 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -1.068K | $7.81 | -$8.34K | SELL | -1.19% | 88.965K | Dec 12 | View |
Jun 29, 2023 | NADIM AHMED | PRESIDENT AND CEO | -759 | $11.40 | -$8.65K | SELL | -0.65% | 115.822K | Jun 28 | View |
Jun 21, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -387 | $12.94 | -$5.01K | SELL | -0.66% | 58.437K | Jun 20 | View |
Jun 21, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -238 | $12.94 | -$3.08K | SELL | -0.26% | 90.033K | Jun 20 | View |
Jun 21, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -399 | $12.94 | -$5.16K | SELL | -0.46% | 85.823K | Jun 20 | View |
Jun 21, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -291 | $12.94 | -$3.77K | SELL | -0.63% | 45.823K | Jun 20 | View |
Jun 14, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -319 | $13.11 | -$4.18K | SELL | -0.37% | 86.222K | Jun 12 | View |
Jun 14, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -176 | $13.11 | -$2.31K | SELL | -0.19% | 90.271K | Jun 12 | View |
Jun 08, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | 0 | $8.31 | -$96.13K | SELL-OPTIONS | 0.00% | 90.447K | Jun 06 - Jun 07 | View |
May 24, 2023 | NADIM AHMED | PRESIDENT AND CEO | -707 | $9.15 | -$6.47K | SELL | -0.60% | 116.581K | May 23 | View |
May 19, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -239 | $8.76 | -$2.09K | SELL | -0.26% | 90.447K | May 18 | View |
May 19, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -394 | $8.76 | -$3.45K | SELL | -0.67% | 58.824K | May 18 | View |
May 19, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -291 | $8.76 | -$2.55K | SELL | -0.63% | 46.114K | May 18 | View |
May 19, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -399 | $8.76 | -$3.50K | SELL | -0.46% | 86.541K | May 18 | View |
May 16, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -193 | $8.78 | -$1.69K | SELL | -0.21% | 90.686K | May 12 | View |
May 16, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -347 | $8.78 | -$3.05K | SELL | -0.40% | 86.94K | May 12 | View |
Apr 26, 2023 | NADIM AHMED | PRESIDENT AND CEO | -716 | $10.59 | -$7.58K | SELL | -0.61% | 117.288K | Apr 25 | View |
Apr 20, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -392 | $10.71 | -$4.20K | SELL | -0.66% | 59.218K | Apr 18 | View |
Apr 20, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -398 | $10.71 | -$4.26K | SELL | -0.45% | 87.287K | Apr 18 | View |
Apr 20, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -238 | $10.71 | -$2.55K | SELL | -0.26% | 90.879K | Apr 18 | View |
Apr 20, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -290 | $10.71 | -$3.11K | SELL | -0.62% | 46.405K | Apr 18 | View |
Apr 14, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -318 | $10.22 | -$3.25K | SELL | -0.36% | 87.685K | Apr 12 | View |
Apr 14, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -176 | $10.22 | -$1.80K | SELL | -0.19% | 91.117K | Apr 12 | View |
Mar 27, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -399 | $11.32 | -$4.52K | SELL | -0.45% | 88.003K | Mar 20 | View |
Mar 27, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -390 | $11.32 | -$4.41K | SELL | -0.65% | 59.61K | Mar 20 | View |
Mar 27, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -238 | $11.32 | -$2.69K | SELL | -0.26% | 91.293K | Mar 20 | View |
Mar 27, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -305 | $11.32 | -$3.45K | SELL | -0.65% | 46.695K | Mar 20 | View |
Mar 27, 2023 | NADIM AHMED | PRESIDENT AND CEO | -706 | $10.51 | -$7.42K | SELL | -0.59% | 118.004K | Mar 23 | View |
Nov 29, 2022 | Jennifer Michaelson | SEE REMARKS | 0 | $8.80 | -$36.00K | SELL-OPTIONS | 0.00% | 53.031K | Nov 25 | View |
Sep 29, 2022 | Jennifer Michaelson | SEE REMARKS | 0 | $8.35 | -$32.40K | SELL-OPTIONS | 0.00% | 53.031K | Sep 27 | View |
Aug 09, 2022 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | 0 | $9.65 | -$14.83K | SELL-OPTIONS | 0.00% | 53.031K | Aug 08 | View |
Aug 04, 2022 | SCS VisionMorana JovanEmbiricos | 10% OWNER | -49.91K | $14.26 | -$711.68K | SELL | -3.30% | 1.463766M | Aug 02 - Aug 04 | View |
Jul 26, 2022 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | 0 | $9.40 | -$81.68K | SELL-OPTIONS | 0.00% | 53.031K | Jul 25 | View |
Jul 21, 2022 | Corrine Savill | ACTING CHIEF BUSINESS OFFICER | -20K | $15.18 | -$303.59K | SELL | -11.79% | 149.615K | Jul 18 - Jul 19 | View |
Jul 12, 2022 | Corrine Savill | ACTING CHIEF BUSINESS OFFICER | -40K | $13.33 | -$533.30K | SELL | -19.08% | 169.615K | Jul 11 | View |
Jun 23, 2022 | F Bioscience I LtdMorana JovanEmbiricos | 10% OWNER | -101.903K | $12.80 | -$1.30M | SELL | -13.55% | 649.899K | Jun 21 - Jun 23 | View |
Jun 07, 2022 | NADIM AHMED | PRESIDENT AND CEO | 8.09K | $12.40 | $100.32K | BUY | ∞ | 8.09K | Jun 06 | View |
Jun 03, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 751.396K | $11.00 | $8.26M | BUY | ∞ | 364.161K | Jun 01 | View |
May 16, 2022 | SCS VisionMorana JovanEmbiricos | 10% OWNER | -418.738K | $9.66 | -$4.05M | SELL | -22.79% | 1.41838M | May 12 - May 16 | View |
May 16, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 1.1099M | $9.07 | $10.06M | BUY | ∞ | 319.415K | May 12 - May 13 | View |
Apr 05, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 276K | $10.75 | $2.97M | BUY | 12.42% | 2.497911M | Apr 01 | View |
Oct 20, 2021 | Jennifer Michaelson | SEE REMARKS | 0 | $12.86 | -$68.47K | SELL-OPTIONS | 0.00% | 22.911K | Oct 18 | View |
Oct 18, 2021 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | 0 | $14.65 | -$165.60K | SELL-OPTIONS | 0.00% | 2.25K | Oct 15 | View |
Oct 18, 2021 | Leigh Zawel | SEE REMARKS | -19.574K | $25.00 | -$489.35K | SELL | -34.43% | 37.285K | Oct 15 | View |
Oct 12, 2021 | Leigh Zawel | SEE REMARKS | -1.079K | $25.00 | -$26.98K | SELL | -1.86% | 56.859K | Oct 07 | View |
Sep 21, 2021 | Jennifer Michaelson | SEE REMARKS | 0 | $14.41 | -$80.85K | SELL-OPTIONS | 0.00% | 22.911K | Sep 20 | View |
Sep 21, 2021 | Leigh Zawel | SEE REMARKS | -7.468K | $25.16 | -$187.89K | SELL | -11.42% | 57.938K | Sep 20 | View |
Sep 20, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -3.124K | $29.06 | -$90.78K | SELL | -0.04% | 7.648268M | Sep 16 | View |
Sep 20, 2021 | Ansbert Gadicke | DIRECTOR | -3.556K | $29.06 | -$103.34K | SELL | -0.05% | 7.648268M | Sep 16 | View |
Sep 16, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -13.531K | $29.17 | -$394.64K | SELL | -0.18% | 7.651392M | Sep 14 - Sep 15 | View |
Sep 16, 2021 | Ansbert Gadicke | DIRECTOR | -15.401K | $29.17 | -$449.17K | SELL | -0.20% | 7.651392M | Sep 14 - Sep 15 | View |
Sep 13, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -23.253K | $29.23 | -$679.74K | SELL | -0.30% | 7.664923M | Sep 09 - Sep 13 | View |
Sep 13, 2021 | Ansbert Gadicke | DIRECTOR | -26.468K | $29.23 | -$773.72K | SELL | -0.34% | 7.664923M | Sep 09 - Sep 13 | View |
Sep 09, 2021 | Patrick Baeuerle | SEE REMARKS | 0 | $16.38 | -$265.65K | SELL-OPTIONS | 0.00% | 341.434K | Sep 08 | View |
Sep 09, 2021 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | 0 | $16.39 | -$362.65K | SELL-OPTIONS | 0.00% | 2.25K | Sep 08 | View |
Sep 08, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -48.64K | $29.20 | -$1.42M | SELL | -0.63% | 7.688176M | Sep 03 - Sep 08 | View |
Sep 08, 2021 | Ansbert Gadicke | DIRECTOR | -55.364K | $29.20 | -$1.62M | SELL | -0.71% | 7.688176M | Sep 03 - Sep 08 | View |
Sep 08, 2021 | Leigh Zawel | SEE REMARKS | -28.118K | $28.95 | -$814.02K | SELL | -30.07% | 65.406K | Sep 07 | View |
Sep 02, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -24.309K | $29.50 | -$717.22K | SELL | -0.31% | 7.736816M | Aug 31 - Sep 02 | View |
Sep 02, 2021 | Ansbert Gadicke | DIRECTOR | -27.669K | $29.50 | -$816.35K | SELL | -0.36% | 7.736816M | Aug 31 - Sep 02 | View |
Aug 31, 2021 | Ansbert Gadicke | DIRECTOR | -50.489K | $29.24 | -$1.48M | SELL | -0.65% | 7.761125M | Aug 27 - Aug 30 | View |
Aug 31, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -44.358K | $29.24 | -$1.30M | SELL | -0.57% | 7.761125M | Aug 27 - Aug 30 | View |
Aug 26, 2021 | Patrick Baeuerle | SEE REMARKS | 0 | $15.65 | -$249.70K | SELL-OPTIONS | 0.00% | 341.434K | Aug 10 | View |
Aug 25, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLCMPM Oncology Impact Management LP | 10% OWNER | -105.894K | $29.29 | -$3.10M | SELL | -1.34% | 7.805483M | Aug 23 - Aug 25 | View |
Aug 25, 2021 | Ansbert Gadicke | DIRECTOR | -120.592K | $29.29 | -$3.53M | SELL | -1.52% | 7.805483M | Aug 23 - Aug 25 | View |
Aug 24, 2021 | Leigh Zawel | SEE REMARKS | -28.118K | $29.00 | -$815.42K | SELL | -23.12% | 93.524K | Aug 23 | View |
Aug 24, 2021 | Jennifer Michaelson | SEE REMARKS | 0 | $15.98 | -$93.45K | SELL-OPTIONS | 0.00% | 22.911K | Aug 18 | View |
Aug 12, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLCMPM Oncology Impact Management LP | 10% OWNER | -2.51K | $29.05 | -$72.92K | SELL | -0.03% | 7.911377M | Aug 11 | View |
Aug 12, 2021 | Ansbert Gadicke | DIRECTOR | -2.857K | $29.05 | -$83.00K | SELL | -0.04% | 7.911377M | Aug 11 | View |
Aug 11, 2021 | Leigh Zawel | SEE REMARKS | -28.118K | $26.77 | -$752.85K | SELL | -18.78% | 121.642K | Aug 09 - Aug 10 | View |
Jan 14, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLCMPM Oncology Impact Management LP | 10% OWNER | 7.913887M | $21.00 | $6.30M | BUY | ∞ | 7.913887M | Jan 12 | View |
Jan 14, 2021 | Ansbert Gadicke | DIRECTOR | 8.195155M | $21.00 | $6.30M | BUY | ∞ | 7.913887M | Jan 07 - Jan 12 | View |
Jan 14, 2021 | Morana JovanEmbiricosGlobeways Holdings LtdSCS VisionF Bioscience I LtdF MG LtdF TPO Investments LLCF Bio TD LLCF MC LLCF GC LLC | DIRECTOR | 6.026832M | $21.00 | $4.20M | BUY | ∞ | 217.269K | Jan 12 | View |
Jan 14, 2021 | Owen Hughes | PRESIDENT AND CEO | 2.5K | $21.00 | $52.50K | BUY | 0.50% | 506.226K | Jan 12 | View |
Jan 14, 2021 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | 2.25K | $21.00 | $47.25K | BUY | ∞ | 2.25K | Jan 12 | View |
Browse insider trades on all stocks.